How many institutions held KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share in Q2 2022?

142 institutional investors reported KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share for Q2 2022. Use the holders table for investor-level position and value details.

Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA)

Q: What does CUSIP 50127T109 represent in this 13F holders report?

CUSIP 50127T109 is the security identifier for KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 50127T109

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 88,321,513
Total 13F shares: 68,658,415
Share change: +2,885,225
Total reported value: $1,258,498,156
Put/Call ratio: 32%
Price per share: $18.33
Number of holders: 142
Value change: +$54,233,601
Number of buys: 58
Number of sells: 67

Quarterly Holders Quick Answers

What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 50127T109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
EcoR1 Capital, LLC	13F	Company	7.5%	6,638,371	$106,745,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	5.6%	4,947,345	$79,554,000	—	31 Mar 2022	13F
Avoro Capital Advisors LLC	13F	Company	5.4%	4,800,000	$77,184,000	—	31 Mar 2022	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	5%	4,416,361	$71,015,000	—	31 Mar 2022	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	4.4%	3,893,019	$62,600,000	—	31 Mar 2022	13F
Aaron Wealth Advisors LLC	13F	Company	1%	910,690	$56,635,000	—	31 Mar 2022	13F
Deep Track Capital, LP	13F	Company	3.9%	3,412,000	$54,865,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	3.8%	3,330,346	$53,553,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	3.7%	3,300,748	$53,076,000	—	31 Mar 2022	13F
Holocene Advisors, LP	13F	Company	3.7%	3,242,808	$52,144,000	—	31 Mar 2022	13F
BVF INC/IL	13F	Company	3.6%	3,203,783	$51,517,000	—	31 Mar 2022	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	2.3%	2,061,044	$33,142,000	—	31 Mar 2022	13F
Foresite Capital Management IV, LLC	13F	Company	2.1%	1,849,947	$29,747,000	—	31 Mar 2022	13F
Assenagon Asset Management S.A.	13F	Company	1.9%	1,680,196	$27,018,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	1,107,777	$17,813,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.2%	1,070,685	$17,217,000	—	31 Mar 2022	13F
Artal Group S.A.	13F	Company	1.2%	1,050,000	$16,884,000	—	31 Mar 2022	13F
Affinity Asset Advisors, LLC	13F	Company	1%	924,147	$14,860,000	—	31 Mar 2022	13F
Commodore Capital LP	13F	Company	0.88%	776,514	$12,486,000	—	31 Mar 2022	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.87%	770,889	$12,395,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.74%	653,548	$10,509,000	—	31 Mar 2022	13F
FRANKLIN RESOURCES INC	13F	Company	0.71%	625,894	$10,064,000	—	31 Mar 2022	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.7%	618,244	$9,941,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.59%	525,186	$8,351,000	—	31 Mar 2022	13F
TCG Crossover Management, LLC	13F	Company	0.57%	506,423	$8,143,000	—	31 Mar 2022	13F
Verition Fund Management LLC	13F	Company	0.56%	493,138	$7,930,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.54%	481,190	$7,738,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.54%	477,917	$7,685,000	—	31 Mar 2022	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.54%	473,969	$7,621,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.5%	444,840	$7,154,000	—	31 Mar 2022	13F
S.c.a. Candriam	13F	Individual	0.5%	438,297	$7,047,000	—	31 Mar 2022	13F
AXA S.A.	13F	Company	0.42%	371,640	$5,975,971	—	31 Mar 2022	13F
ALETHEA CAPITAL MANAGEMENT, LLC	13F	Company	0.4%	357,620	$5,751,000	—	31 Mar 2022	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.4%	350,531	$5,636,537	—	31 Mar 2022	13F
Integral Health Asset Management, LLC	13F	Company	0.38%	337,000	$5,419,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.32%	278,400	$4,477,000	—	31 Mar 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	0.31%	274,458	$4,413,000	—	31 Mar 2022	13F
Woodline Partners LP	13F	Company	0.3%	267,683	$4,304,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.3%	267,100	$4,295,000	—	31 Mar 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.28%	250,000	$4,020,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.28%	248,548	$3,997,000	—	31 Mar 2022	13F
Lombard Odier Asset Management (Switzerland) SA	13F	Company	0.27%	234,372	$3,769,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.26%	231,653	$3,724,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.25%	217,751	$3,501,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	0.21%	188,819	$3,036,000	—	31 Mar 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.21%	181,083	$2,912,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.18%	155,997	$2,508,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.17%	153,733	$2,472,000	—	31 Mar 2022	13F
HighVista Strategies LLC	13F	Company	0.17%	147,833	$2,377,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.17%	146,273	$2,352,000	—	31 Mar 2022	13F

Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q2 2022

As of 30 Jun 2022, Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) was held by 142 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 68,658,415 shares. The largest 10 holders included EcoR1 Capital, LLC, BlackRock Inc., Avoro Capital Advisors LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Deep Track Capital, LP, VANGUARD GROUP INC, Holocene Advisors, LP, BVF INC/IL, STATE STREET CORP, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). This page lists 142 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

142

Q2 2022 holders

142

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.